A Nashik-based maker of rotational-moulding compounds opens its Rs 14.58 crore BSE SME issue on August 31
A manufacturer of rotational-moulding compounds tailored to user-industry specifications plans to raise Rs 14.58 crore via an SME listing on BSE SME.
Phychem Technologies Ltd (PTL), a Nashik-based specialist in polyethylene-based roto-moulding compounds with exports to over 20 countries, opens for subscription on August 31 with the issue closing on September 2.
The company occupies a specialised upstream niche in the plastics value chain — the manufacture of rotational-moulding (roto-moulding) compounds, which serve as a key raw material for producing a wide range of hollow plastic products through the rotational-moulding process.
Its portfolio is built around customised polyethylene-based compounds formulated using Linear Low-Density Polyethylene (LLDPE), High-Density Polyethylene (HDPE) and specialty additives, supplied in powder or granulated form to roto-moulding manufacturers.
These compounds are a critical input for everyday industrial and infrastructure products — water, fuel and chemical storage tanks, portable sanitation units, furniture, industrial containers and other customised hollow plastic parts.
PTL’s process runs through blending, pelletizing and pulverization, followed by quality control to ensure uniform particle size, optimal melt flow and consistent end-use performance.
Its formulation capability lets it deliver differentiated variants — foam compound, stone effect, flame-retardant, anti-static and custom-coloured compounds — depending on client needs, serving building and construction, water management, agriculture, automotive and consumer-products industries.
Beyond compound manufacturing, PTL runs two complementary revenue streams. It produces custom-moulded tanks for diverse applications, and provides job-work services including roto lining (internal lining of tanks and equipment for chemical resistance and durability) and toll pulverizing (custom grinding of polymers into powder per client specifications).
It also earns from distribution — as an authorised distributor of imported chemicals and compounds (paints and coatings from the UK, polypropylene compound from Thailand, specialty release agents from the USA) and roto-moulding tools and equipment (process-control equipment from Northern Ireland, plastic welding machines from Canada, ancillary tools from the UK). Manufacturing contributes around 94% of revenue, with the rest from service and trading.
The company’s credentials support its export orientation. Its facility at Khatwad, Dindori, Nashik, has an in-house laboratory and quality-control department, is ISO 9001:2015 certified, and is recognised as a One Star Export House by the Ministry of Commerce and Industry.
PTL is a member of the Plastics Export Promotion Council (PLEXCONCIL) and exports to a broad list of countries including Bahrain, Bangladesh, Iraq, Kuwait, Nepal, Nigeria, Oman, Poland, Russia, Saudi Arabia, South Africa, Taiwan, Thailand, Turkey and the UAE. As of June 30, 2026, it had 33 employees on its payroll.
Issue Details
| Particulars | Details |
|---|---|
| Issue Opens | August 31, 2026 |
| Issue Closes | September 2, 2026 |
| Listing | BSE SME |
| Listing Date | September 7, 2026 |
| Issue Type | Book Built |
| Price Band | Rs 51 – Rs 54 per share |
| Face Value | Rs 10 |
| Issue Size | Rs 14.58 crore (27,00,000 shares, entirely fresh) |
| Min. Application | 4,000 shares (multiples of 2,000 thereafter) |
| Min. Retail Investment | Rs 2,16,000 |
| Post-IPO Market Cap | Rs 55.30 crore |
| IPO as % of Post-IPO Capital | 26.37% |
| Lead Manager | Hem Securities Ltd. |
| Market Maker | Hem Finlease Pvt. Ltd. |
| Registrar | MUFG Intime India Pvt. Ltd. |
The issue is entirely a fresh issue. From the net proceeds, the company will utilise Rs 5.15 crore for capex on procurement of plant and machinery, Rs 3.00 crore for working capital, Rs 2.50 crore for repayment of certain borrowings, and the rest for general corporate purposes.
Two capital markers stand out. Post-IPO, paid-up equity capital rises only modestly from Rs 7.54 crore (75,40,000 shares) to Rs 10.24 crore (1,02,40,000 shares) — a small base that typically implies a longer gestation period before the company can qualify to migrate from the SME board to the mainboard.
And the pre-IPO history is worth noting: after issuing initial capital at par, the company issued bonus shares in a hefty 25:1 ratio in September 2025, and the promoters’ average cost of acquisition is just Rs 0.00, Rs 0.05 and Rs 0.38 per share — against a Rs 54 offer price.
GMP Watch
Grey-market interest has been minimal. In tracked data, the Phychem Technologies IPO GMP stood at around ₹3 as of late August, having recorded a high and low of ₹3 on August 27 — implying a listing gain of only about 6% over the Rs 54 upper band. As always, GMP is unofficial, unregulated and for a thin SME grey market can move on low volume
Financial Performance
| Particulars (Rs cr) | FY24 | FY25 | FY26 |
|---|---|---|---|
| Total Income | 47.59 | 51.11 | 57.48 |
| Net Profit (PAT) | 1.69 | 2.84 | 4.09 |
| PAT Margin (%) | 3.61 | 5.65 | 7.24 |
| RoCE (%) | 23.27 | 31.99 | 32.73 |
Revenue has grown steadily — from Rs 47.59 crore in FY24 to Rs 57.48 crore in FY26 — a measured trajectory rather than a pre-IPO surge. The more encouraging story is profitability: net profit more than doubled from Rs 1.69 crore to Rs 4.09 crore over the same span, with PAT margin expanding consistently from 3.61% to 7.24%.
That steady margin improvement, alongside a rising RoCE (from 23.27% to 32.73%), points to genuine operating leverage rather than a one-off jump.
The company reported an average EPS of about Rs 4.34 and an average RoNW of 28.71% over the last three fiscals. On book value, the issue is priced at a P/BV of 2.95 on the March 31, 2026 NAV of Rs 18.29 (the post-IPO NAV disclosure in the offer document is garbled).
On earnings, the picture depends on the anchor: annualise the FY26 earnings onto the post-IPO fully-diluted capital and the P/E is about 13.53x; on FY25 earnings it works out to 19.42x. On recent average earnings, the issue looks fully priced rather than cheap.
Peer Comparison
As per the offer document, the company has no listed peers to compare with. That leaves the valuation without a direct benchmark, so the fully-priced tag rests on the company’s own average earnings and book value rather than a peer multiple.
Risks to Consider
Full valuation limits upside. On recent average earnings the issue is fully priced (FY26 annualised P/E of 13.53x, FY25 P/E of 19.42x, P/BV of 2.95x), and with no listed peer to anchor it, there is little valuation cushion if growth or margins disappoint.
The small post-IPO equity base of Rs 10.24 crore implies a longer gestation before any mainboard migration, which can keep liquidity thin and the stock range-bound on the SME platform for an extended period.
Raw-material dependence is structural. The compounds are polyethylene-based (LLDPE, HDPE), so margins are exposed to polymer- and crude-linked input-price volatility, which can compress profitability if not passed through.
Scale and margin modesty are inherent — the company remains small (Rs 57 crore of income, 33 employees, one facility) and operates at modest single-digit-to-low-teens margins, leaving limited buffer to absorb cost or demand shocks.
Export and concentration exposure adds risk — a meaningful share of revenue comes from exports (including to Russia), and all manufacturing is concentrated at a single Nashik facility, exposing operations to regional and trade-related disruptions.